Sam Boong Park Sells 3,525 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) Stock

Sight Sciences, Inc. (NASDAQ:SGHT) COO Sam Boong Park sold 3,525 shares of the firm’s stock in a transaction that occurred on Tuesday, July 2nd. The shares were sold at an average price of $6.21, for a total transaction of $21,890.25. Following the completion of the sale, the chief operating officer now owns 258,229 shares of the company’s stock, valued at $1,603,602.09. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Sight Sciences Stock Up 0.5 %

Shares of SGHT opened at $6.19 on Friday. The company has a debt-to-equity ratio of 0.31, a current ratio of 13.01 and a quick ratio of 12.42. The company’s fifty day moving average price is $6.09 and its 200-day moving average price is $5.26. Sight Sciences, Inc. has a 1-year low of $1.04 and a 1-year high of $9.31.

Sight Sciences (NASDAQ:SGHT) last announced its quarterly earnings data on Thursday, May 2nd. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.29) by ($0.04). Sight Sciences had a negative return on equity of 44.45% and a negative net margin of 67.18%. The firm had revenue of $19.27 million during the quarter, compared to analysts’ expectations of $18.34 million. Sell-side analysts anticipate that Sight Sciences, Inc. will post -1.13 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on SGHT shares. Needham & Company LLC reiterated a “hold” rating on shares of Sight Sciences in a report on Friday, May 3rd. Piper Sandler reissued a “neutral” rating and issued a $6.00 price target (up previously from $5.00) on shares of Sight Sciences in a report on Friday, May 3rd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $4.70.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. State Board of Administration of Florida Retirement System purchased a new stake in Sight Sciences in the first quarter valued at $59,000. Tower Research Capital LLC TRC raised its stake in shares of Sight Sciences by 180.1% during the 4th quarter. Tower Research Capital LLC TRC now owns 12,076 shares of the company’s stock valued at $62,000 after buying an additional 7,764 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Sight Sciences by 51.9% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,653 shares of the company’s stock valued at $141,000 after buying an additional 9,106 shares during the period. Federated Hermes Inc. boosted its stake in shares of Sight Sciences by 100.0% in the third quarter. Federated Hermes Inc. now owns 60,000 shares of the company’s stock worth $202,000 after buying an additional 30,000 shares during the last quarter. Finally, Panagora Asset Management Inc. grew its holdings in Sight Sciences by 198.1% during the fourth quarter. Panagora Asset Management Inc. now owns 59,190 shares of the company’s stock worth $305,000 after acquiring an additional 39,333 shares during the period. Hedge funds and other institutional investors own 55.51% of the company’s stock.

Sight Sciences Company Profile

Sight Sciences, Inc, an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork.